Catalog name Description price
R-R-4101 CB2R PAM CAS No.2244579-87-9 CB2R PAM/CAS No.2244579-87-9 is an orally active cannabinoid type-2 receptors (CB2Rs) positive allosteric modulator. CB2R PAM displays antinociceptive activity in vivo in an experimental mouse model of neuropathic pain. price>
R-R-4102 CB1 agonist 1 CAS No.851212-80-1 CB1 agonist 1 (compound 22)/CAS No.851212-80-1 is an agonist of CB1. CB1 agonist 1 shows affinity to CB1 receptor with an pIC50 value of 5.7. CB1 agonist 1 can be used for the research of brain disorders. price>
R-C-2403 Atipamezole CAS:104054-27-5 Atipamezole(MPV-1248,MPV1248,Antisedan)is a synthetic α2 adrenergic receptor antagonist.It has also been researched in humans as a potential anti-Parkinsonian drug. price>
R-R-4103 Taranabant racemate CAS No.701977-00-6 Taranabant racemate (MK-0364 racemate)/CAS No.701977-00-6 is an antagonist and/or inverse agonist of the Cannabinoid-1 (CB1) receptor extracted from patent WO 2004048317 A1. price>
R-R-4104 SCH 336 CAS No.447459-51-0 SCH 336/CAS No.447459-51-0 is a potent, selective, inverse and orally active CB2 agonist. SCH 336 inhibits BaF3/CB2 migration. SCH 336 significantly inhibits the migration of leukocytes in vivo. SCH 336 blocks ovalbumin-induced lung eosinophilia in mice. price>
R-R-4105 Tetrahydromagnolol CAS No.20601-85-8 Tetrahydromagnolol (Magnolignan)/CAS No.20601-85-8, a main metabolite of Magnolol, is a potent and selective cannabinoid CB2 receptor agonist with an EC50 of 170 nM and a Ki of 416 nM. Tetrahydromagnolol possesses 20-fold more selective for CB2 receptor than CB1 receptor. Tetrahydromagnolol is also a weak GPR55 receptor antagonist. price>
R-R-4106 AZD1940 CAS No.881413-29-2 AZD1940/CAS No.881413-29-2 is an orally active, high affinity cannabinoid CB1/CB2 receptor agonist with pKi values of 7.93 and 9.06 for human CB1R and CB2R, respectively. AZD1940 shows a robust analgesia action. price>
R-R-4107 Vicasinabin CAS No.1433361-02-4 Vicasinabin (RG7774)/CAS No.1433361-02-4 is the potent agonist of cannabinoid receptor 2 (CB2). Vicasinabin has the potential for the research of human diseases including chronic pain, atherosclerosis, regulation of bone mass, neuroinflammation, and other related diseases (extracted from patent US20130116236A1). price>
R-R-4108 LH21 CAS No.611207-11-5 LH-21/CAS No.611207-11-5 is a potent in vivo neutral cannabinoid CB1 receptor antagonist. LH-21 reduces food intake and body weight gain in obese Zucker rats. , and displays efficacy as a feeding inhibitor. price>
R-R-4109 S-777469 CAS No.885496-53-7 S-777469/CAS No.885496-53-7 is a selective and orally available cannabinoid type 2 receptor (CB2) agonist with a Ki of 36 nM. S-777469 significantly suppresses compound 48/80-induced scratching behavior in mice in a dose-dependent manner. S-777469 produces its antipruritic effects by inhibiting itch signal transmission through CB2 agonism. price>